Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ABBOTT LABORATORIES Stock Hits Forecast Target with 10.04% Profit

January 23, 2025
On August 27, 2024, QuantWave's automated forecasting platform issued a long signal for ABBOTT LABORATORIES at a price of 110.97 $. After nearly five months, on January 23, 2025, the stock successfully reached the forecasted target price of 122.1 $, resulting in a profit of 10.04%.

This achievement showcases the accuracy and effectiveness of QuantWave's analytics in predicting stock movements. The positive outcome for ABBOTT LABORATORIES can be attributed to a combination of strong market fundamentals, successful strategy implementation by the company, and overall market sentiment.

QuantWave's ability to accurately forecast price targets enables users to capitalize on opportunities for significant profits. As an automated forecasting platform, QuantWave provides valuable insights and predictions for a wide range of stocks, offering potential gains for investors.

For investors interested in exploring further, QuantWave recommends utilizing QuantSchool – a professional investment framework that delves into the key principles for generating consistent income using the QuantWave forecasting system.
If you want to leave a comment, then you need Login or Register





Other data for ABT

Related data

ABTAugust 9, 2025Abbott Laboratories NYSE:ABT Earnings Are Of Questionable Quality  ~1 min.

Abbott Laboratories recently reported their second quarter 2025 earnings, with EPS exceeding expectations....


ABTJune 5, 2025Abbott Laboratories ABT is Attracting Investor Attention: Here is What You Should Know  ~1 min.

Abbott Laboratories (ABT) has been making waves in the healthcare sector, attracting attention from investors around the globe....


ABTMarch 18, 2025Abbott Laboratories Continues to Drive Growth in the Healthcare Sector  ~2 min.

Abbott Laboratories (ABT) has emerged as a top player in the healthcare industry, making it an attractive stock for long-term investors....


ABTMarch 17, 2025Abbott Laboratories: A Leader in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) is a renowned healthcare company that has caught the attention of investors and industry experts alike....


ABTMarch 16, 2025Abbott Laboratories: Breaking New Ground in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making waves in the healthcare industry with its groundbreaking innovations....


ABTMarch 15, 2025Abbott Laboratories: A Healthcare Stock With Long-Term Investment Potential  ~2 min.

Abbott Laboratories (NYSE:ABT) is a renowned healthcare company that has been delivering groundbreaking medical technologies and products for decades....


ABTFebruary 26, 2025Abbott Laboratories Continues to Deliver Strong Earnings Growth  ~2 min.

Abbott Laboratories, a leading global healthcare company, has reported steady growth in earnings over the past five years....


ABTFebruary 22, 2025Abbott Laboratories: A Rising Star in the Pharmaceutical Industry  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making significant progress in the pharmaceutical industry, positioning itself as one of the best drug stocks to buy now....


ABTFebruary 21, 2025Abbott Laboratories NYSE:ABT: A Leading Drug Stock with Promising Future  ~1 min.

Abbott Laboratories, a renowned pharmaceutical company, has emerged as one of the best drug stocks to invest in....


ABTFebruary 21, 2025ABBOTT LABORATORIES Stock Hits Price Target with 16.11% Profit: QuantWave Forecast Success  ~2 min.

On December 2, 2024, QuantWave, the automated forecasting platform, issued a long signal for ABBOTT LABORATORIES stock when it was trading at 115.66 $....


ABTJanuary 1, 2025Abbott Laboratories ABT: An In-Depth Analysis on Diamond Hill Capitals Top Stock Picks  ~2 min.

In a recent analysis conducted by Diamond Hill Capital, Abbott Laboratories (NYSE:ABT) emerged as one of the top stock picks....


ABTDecember 20, 2024Abbott Laboratories Continues to Impress with Strong Fundamentals  ~2 min.

Abbott Laboratories (NYSE:ABT) has been garnering attention in the stock market lately, as investors became wary of its recent weakness....


ABTFebruary 21, 2024ABBOTT LABORATORIES Hits Price Target Forecast with 11.61% Profit  ~1 min.

QuantWave, an automated forecasting platform, successfully predicted the price movement of ABBOTT LABORATORIES stock, achieving an 11.61% profit on the forecasted long position....


ABTDecember 20, 2024Abbott Laboratories Continues to Deliver Strong Fundamentals Amid Recent Weakness  ~1 min.

Despite recent weakness in the stock, Abbott Laboratories (NYSE:ABT) remains a solid investment option with strong fundamentals....


ABTJanuary 2, 2025Abbott Laboratories' Fundamental Strengths Signal Future Market Correction: Stocks Prognosis  ~1 min.

Abbott Laboratories, a global healthcare company, has lately witnessed a decline in its stock performance....